Annals of Epidemiology
Volume 19, Issue 7 , Pages 494-500 , July 2009

Analysis of the Quality of Reporting of Randomized Controlled Trials in Acute and Chronic Myeloid Leukemia, and Myelodysplastic Syndromes as Governed by the CONSORT Statement

  • Dimitrios C. Ziogas

      Affiliations

    • Department of Biomathematics, University of Thessaly School of Medicine, Larissa, Greece
    • ,
  • Elias Zintzaras

      Affiliations

    • Department of Biomathematics, University of Thessaly School of Medicine, Larissa, Greece
    • Center for Clinical Evidence Synthesis, The Institute for Clinical Research and Health Policy Studies, Tufts–New England Medical Center, Tufts University School of Medicine, Boston, MA
    • Corresponding Author InformationAddress correspondence to: Elias Zintzaras, Head, Department of Biomathematics, University of Thessaly School of Medicine, Papauyriazi 22, Larissa 41222, Greece. Tel/Fax: +30-2410-56506.

Received 1 August 2008 ,Accepted 17 March 2009.

References 

  1. Djulbegovic B, Loughran T, Hornung CA, Kloecker G, Efthimiadis EN, Hadley TJ, et al. The quality of medical evidence in hematology-oncology. Am J Med. 1999;106:198–205
  2. Moher D, Jadad AR, Tugwell P. Assessing the quality of randomized controlled trials. Current issues and future directions. Int J Technol Assess Health Care. 1996;12:195–208
  3. Altman DG. Better reporting of randomised controlled trials: the CONSORT statement. BMJ. 1996;313:570–571
  4. Kober T, Trelle S, Engert A. Reporting of Randomized Controlled Trials in Hodgkin Lymphoma in Biomedical Journals. J Natl Cancer Inst. 2006;98:620–625
  5. Bonadonna G, Valagussa P. Influence of clinical trials on current treatment strategy for Hodgkin's disease. Int J Radiat Oncol Biol Phys. 1990;19:209–218
  6. Pfeifer M, Snodgrass GL. The continued use of retracted invalid scientific literature. JAMA. 1999;263:1420–1423
  7. Olkin I. Meta-analysis: reconciling the results of independent studies. Stat Med. 1995;14:457–472
  8. Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, et al. Does quality of reports of randomized trials affect estimates of intervention efficacy reported in meta-analyses?. Lancet. 1999;352:609–613
  9. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA. 1995;273:408–412
  10. Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I, et al. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA. 1996;276:637–639
  11. Mills E, Wu P, Gagnier J, Devereaux PJ. The quality of randomized trial reporting in leading medical journals since the revised CONSORT statement. Contemp Clin Trials. 2005;26:480–487
  12. Juni P, Altman DG, Egger M. Systematic reviews in health care: assessing the quality of controlled clinical trials. BMJ. 2001;323:42–46
  13. Hotopf M, Lewis G, Normand C. Putting trials on trial–the costs and consequences of small trials in depression: a systematic review of methodology. J Epidemiol Community Health. 1997;51:354–358
  14. Liberati A, Himel HN, Chalmers TC. A quality assessment of randomized control trials of primary treatment of breast cancer. J Clin Oncol. 1986;4:942–951
  15. Pildal J, Hrobjartsson A, Jorgensen KJ, Hilden J, Altman DG, Gotzsche PC. Impact of allocation concealment on conclusions drawn from meta-analyses of randomized trials. Int J Epidemiol. 2007;36:847–857
  16. Moher D, Schulz KF, Altman DG CONSORT GROUP (Consolidated Standards of Reporting Trials). The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. Ann Intern Med. 2001;134:657–662
  17. Moher D, Schulz KF, Altman D CONSORT Group (Consolidated Standards of Reporting Trials). The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA. 2001;285:1987–1991
  18. Altman DG, Schulz KF, Moher D, Egger M, Davidoff F, Elbourne D, et al. CONSORT GROUP (Consolidated Standards of Reporting Trials) The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med. 2001;134:663–694
  19. Rennie D. CONSORT revised–improving the reporting of randomized trials. JAMA. 2001;285:2006–2007
  20. Moher D, Simera I, Schulz KF, Hoey J, Altman DG. Helping editors, peer reviewers and authors improve the clarity, completeness and transparency of reporting health research. BMC Med. 2008;6:13
  21. Moher D, Jones A, Lepage L. Use of the CONSORT Statement and quality of reports of randomized trials: a comparative before-and-after evaluation. JAMA. 2001;285:1992–1995
  22. Plint A, Moher D, Morrison A, Schulz K, Altman DG, Hill C, et al. Does the CONSORT checklist improve the quality of reports of randomized controlled trials? A systematic review. Med J Aust. 2006;185:263–267
  23. Rennie D. How to report randomized controlled trials: the CONSORT statement. JAMA. 1996;276:649
  24. McNamee D, Horton R. Lies, damn lies, and reports of RCTs. Lancet. 1996;348:562
  25. Lai TY, Wong VW, Lam RF, Cheng AC, Lam DS, Leung GM. Quality of reporting of key methodological items of randomized controlled trials in clinical ophthalmic journals. Ophthalmic Epidemiol. 2007;14:390–398
  26. Agha R, Cooper D, Muir G. The reporting quality of randomised controlled trials in surgery: a systematic review. Int J Surg. 2007;5:413–422
  27. Hill CL, Buchbinder R, Osborne R. Quality of reporting of randomized clinical trials in abstracts of the 2005 annual meeting of the American College of Rheumatology. J Rheumatol. 2007;34:2476–2480
  28. Farrokhyar F, Chu R, Whitlock R, Thabane L. A systematic review of the quality of publications reporting coronary artery bypass grafting trials. Can J Surg. 2007;50:266–277
  29. Soares H, Daniels S, Kumar A, Clarke M, Scott C, Swann S, et al. Bad reporting does not mean bad methods for randomised trials: observational study of randomised controlled trials performed by the Radiation Therapy Oncology Group. BMJ. 2004;328:22–24
  30. Mills E, Loke YK, Wu P, Montori VM, Perri D, Moher D, et al. Determining the reporting quality of RCTs in clinical pharmacology. Br J Clin Pharmacol. 2004;58:61–65
  31. Le Henanff A, Giraudeau B, Baron G, Ravaud P. Quality of reporting on noninferiority and equivalence randomized trials. JAMA. 2006;295:1147–1151
  32. Piaggio G, Elbourne D, Altman D, Pocock SJ, Evans SJ. CONSORT Group. Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement. JAMA. 2006;295:1152–1160
  33. Colditz G, Miller JN, Mosteller F. How study design affects outcomes in comparisons of therapy. Stat Med. 1989;8:441–454
  34. Huwiler-Müntener K, Jüni P, Junker C, Egger M. Quality of reporting of randomized trials as a measure of methodologic quality. JAMA. 2002;287:2801–2804
  35. Hill C, LaValley MP, Felson DT. Discrepancy between published reports and actual conduct of randomized clinical trials. J Clin Epidemiol. 2002;55:783–786
  36. Altman DG. Endorsement of the CONSORT statement by high impact medical journals: survey of instructions for authors. BMJ. 2005;330:1056–1057
  37. Moher D, Fortin P, Jadad AR, Jüni P, Klassen T, Le Lorier J, et al. Completeness of reporting of trials published in languages other than English: implications for the conduct of systematic reviews. Lancet. 1996;347:363–366

PII: S1047-2797(09)00107-0

doi: 10.1016/j.annepidem.2009.03.018

Annals of Epidemiology
Volume 19, Issue 7 , Pages 494-500 , July 2009

Article Tools

* Image Usage & Resolution